AYUSH drugs being used in prevention of diabetes: Naik
2018-02-07T23:05:55+05:30
New Delhi: Acting on the direction of Prime Minister Narendra Modi to promote the use of traditional medicines to put a check on lifestyle-based diseases; the Ministry of Ayush has included anti-diabetes medicines developed by Council of Scientific & Industrial Research (CSIR), and the Central Council for Research in Ayurvedic Sciences (CCRAS) in ongoing National Health Programme for Prevention of diabetes.
According to Ayush Minister Shripad Yesso Naik, a programme has been started in three districts of the country on a pilot project basis to establish the benefits of the Ayurvedic drug in controlling diabetics. The government has included anti-diabetes drug BGR-34 and CCRAS developed Ayurveda-82 in the programme which has been started in three districts of the country on a pilot project basis.
In a written reply to a question in the Parliament, Naik said that the CCRAS has started this programme in collaboration with the Directorate General of Health Services (DGHS), which is a first time when integrated treatment therapy is being used to prevent any disease.
According to Naik, the Health Ministry has started the National Programme for Prevention and Control of Cancer, Diabetes and Stroke (NPCDCS) for prevention of diabetes, hypertension and cancer. Under the initiative, people are diagnosed with diabetes, cancer and high blood pressure and afflicted one is treated.
"As both the medicines are developed by well-established research institutions, the drugs have been found very effective in controlling diabetic of every stage. The BGR-34 has now been even prescribed by allopathic practitioners, which is enough to explain the efficacy of the drug," said Sanchit Sharma, who represents Aimil Pharmaceuticals.
The treatment facility has been started by the inclusion of integrated AYUSH medicines in 52 community health centres of three districts of Bhilwara (Rajasthan), Surendranagar (Gujarat) and Gaya (Bihar). Out of 2.5 lakh patients who were examined till December 2017, 23,697 diabetes patients are being treated ayurvedic drugs.
